Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to determine the safety and effectiveness of vilazodone for major
depressive disorder and to discover genetic markers associated with response. This study will
enroll approximately 400 patients.